Resources from the same session
6262 - An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23)- EORTC QLQ-BR45
Presenter: Vesna Bjelic-Radisic
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
4295 - Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant: results from MONALEESA-3
Presenter: Peter A. Fasching
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
4241 - Ribociclib (RIB) + tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-7 patient-reported outcomes (PROs)
Presenter: Nadia Harbeck
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
3578 - Patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer and a germline BRCA1/2 mutation (gBRCAm) receiving talazoparib (TALA) vs physician’s choice chemotherapy treatment (PCT): a focus on the EMBRACA triple negative (TNBC) subpopulation
Presenter: Hope Rugo
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
1838 - Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)
Presenter: Eva Ciruelos
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
Proffered paper session - Breast cancer, metastatic - Invited Discussant one LBA TBC and 284O
Presenter: Christophe Le Tourneau
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Slides
Webcast
Introduction: Quality of Life and Clinical Trials
Presenter: Nagi El Saghir
Session: Proffered paper session - Breast cancer, metastatic
Resources:
Slides